Tower Research Capital LLC (Trc) Aura Biosciences, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,216 shares of AURA stock, worth $12,254. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,216
Previous 6,372
65.22%
Holding current value
$12,254
Previous $39,000
66.67%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding AURA
# of Institutions
106Shares Held
52.1MCall Options Held
0Put Options Held
0-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$38.3 Million66.99% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA5.1MShares$28.2 Million1.33% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.88MShares$27 Million0.05% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR4.62MShares$25.5 Million1.06% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.37MShares$24.2 Million0.81% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $162M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...